Tuesday, March 29, 2016 1:01:24 PM
How long is the procedure and any follow up injections?
Answer: Just a few minutes, depending on tumor type. The tumor is injected with a single or multiple injection squirts, depending on various factors. We presume that no follow-up injections will be necessary, although a second treatment could be given if any parts of the tumor survive. Some tumors will need to be reached intraoperatively, meaning that the patient will be anesthetized and opened surgically to access the tumor.
Radiogel comprises a two-part sterile product that is
mixed in precise amounts immediately prior to
injection: Part A is a pre-calibrated, sterile solution of highly insoluble 90Y-phosphate microspheres in a phosphate-buffered saline. Part B is a
sterile isotonic, water-based polymer solution which will act as a microsphere carrier during injection and as a container material after gelation. Parts A and B are cooled in ice, and then combined for injection. The injected solution perfuses tumor tissue and displaces extracellular fluids. As the polymer warms to body temperature, the water-based carrier solution undergoes a phase transition to a solid gel, and the polymers form cross-links that entrap the 90Y microspheres
and prevent redistribution throughout the body. The insoluble phosphate crystal
also prevents dissolution and migration of free 90Y.
The part B is essentially water.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM